Trial Site Detail

 

Drug:
HuF9-G4
Trial:
Phase 1 Trial of Hu5F9-G4, a CD47-targeting Antibody
Conditions: Solid Tumors
Trial Status:
Active, not recruiting

 

Memorial Sloan Kettering

1275 York Ave     
New York , NY 10065
USA

 

Principal Investigator:
Contact:
Activation Status of this Site:
Closed
Notes about this Site:
Memorial Sloan Kettering Website:
http://www.mskcc.org/mskcc/html/2270.cfm?Tab=All

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.